{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"is_locked":false},"authors":[{"name":"Huw Morris","affiliation":"Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK;Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815","affiliation_url":null,"username":"","link":null,"image":{"source":"","placeholder":"","webp_source":""},"note":"","is_verified_user":false},{"name":"Nigel Williams ","affiliation":"MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University","affiliation_url":null,"username":"","link":null,"image":{"source":"","placeholder":"","webp_source":""},"note":"","is_verified_user":false}],"before_start":"{\"blocks\":[{\"key\":\"e119a\",\"text\":\"Check that you have the correct forward and reverse primers and required materials, supplies and equipment.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"e1ils\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1634909742,"creator":{"name":"h.morris ","affiliation":"","affiliation_url":null,"username":"m4wle102z115tle1","link":null,"image":{"source":"/img/avatars/014.png","placeholder":"/img/avatars/014.png","webp_source":""},"badges":[{"id":2,"name":"Author","image":{"source":"/img/badges/bronze.svg","placeholder":"/img/badges/bronze.svg"}}],"affiliations":[]},"description":"{\"blocks\":[{\"key\":\"26sl9\",\"text\":\"This protocol details the steps for GBA genotyping. This protocol has been adapted from the PRoBaND Clinical Consortium (incorporating methods described by Neuman et al., 2009 and Stone et al., 2000) and has been used for all publications for PRoBaND / Tracking Parkinson's describing clinical data and outcomes with respect to GBA status \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":50,\"length\":1}],\"entityRanges\":[{\"key\":0,\"offset\":156,\"length\":19},{\"key\":1,\"offset\":180,\"length\":18}],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"E8423100364811ECBDBA0F99142C8FC6\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/19286695/\"}},\"1\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"F8800F10364811ECBDBA0F99142C8FC6\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-1004(200002)15:2%3C181::AID-HUMU7%3E3.0.CO;2-S\"}}}}","disclaimer":"","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.bzd7p29n","doi_status":1,"fork_id":null,"fork_info":null,"forks":[],"funders":[{"funder_name":"Parkinson’s UK","grant_id":"H-1703"},{"funder_name":"The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Aligning Science Across Parkinson’s (ASAP) initiative","grant_id":"ASAP-000478"}],"groups":[],"guid":"D3B23A50333C11EC83F2ADD01087B07A","guidelines":"{\"blocks\":[{\"key\":\"7pno\",\"text\":\"To avoid amplification of the pseudogene, design primer sequences to DNA regions exclusively found within the GBA gene. \",\"type\":\"unordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":110,\"length\":3}],\"entityRanges\":[],\"data\":{}},{\"key\":\"erqo8\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"i8bp\",\"text\":\"As an internal control, calculate the size of the PCR products resulting from amplification of the GBA pseudogene. \",\"type\":\"unordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":99,\"length\":3}],\"entityRanges\":[],\"data\":{}},{\"key\":\"34doi\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d8q65\",\"text\":\"Refer to Table 2 (Steps) for the PCR conditions for amplification of the GBA gene.\",\"type\":\"unordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":73,\"length\":3}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","has_references":false,"has_versions":false,"id":54431,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":false,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":false,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":839702,"journal":null,"journals":[{"journal_id":"10.1136/jnnp-2021-328365","name":"Journal of Neurology, Neurosurgery, and Psychiatry","group_id":1,"link":"https://doi.org/10.1136/jnnp-2021-328365","citation":"Vijiaratnam N,  Lawton M,  Heslegrave AJ,  Guo T,  Tan M,  Jabbari E,  Real R,  Woodside J,  Grosset K,  Chelban V,  Athauda D,  Girges C,  Barker RA,  Hardy J,  Wood N,  Houlden H,  Williams N,  Ben-Shlomo Y,  Zetterberg H,  Grosset DG,  Foltynie T,  Morris HR,   , Combining biomarkers for prognostic modelling of Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry  93(7). doi: \u003ca target=\"_blank\" href=\"https://dx.doi.org/10.1136/jnnp-2021-328365\"\u003e10.1136/jnnp-2021-328365\u003c/a\u003e ","is_main":false}],"keywords":"Amplification, GBA gene, Genotyping, Intronic Regions, Exons, Parkinson’s disease, PCR, Sequencing,ASAPCRN","last_modified":1659644640,"link":"https://doi.org/10.1136/jnnp-2021-328365","location":null,"manuscript_citation":"\u003cp\u003eMalek, N., Weil, R. S., Bresner, C., Lawton, M. A., Grosset, K. A., Tan, M., Bajaj, N., Barker, R. A., Burn, D. J., Foltynie, T., Hardy, J., Wood, N. W., Ben-Shlomo, Y., Williams, N. W., Grosset, D. G., Morris, H. R., \u0026amp; PRoBaND clinical consortium. (2018). Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study. Journal of Neurology, Neurosurgery, and Psychiatry. https://doi.org/10.1136/jnnp-2017-317348\u003c/p\u003e","materials":[],"materials_text":"{\"blocks\":[{\"key\":\"2lghb\",\"text\":\"Fast start PCR master mix (Roche) - https://lifescience.roche.com/en_gb/products/faststart-essential-dna-probes-master.html\",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":36,\"length\":87}],\"data\":{}},{\"key\":\"b3ev4\",\"text\":\"Primers \",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"esc56\",\"text\":\"Deionised water \",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"adm59\",\"text\":\"Genomic DNA template (50 ng/µl)\",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7oe3n\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"F2CBB5CB36ED11EC8E100A58A9FEAC02\",\"url\":\"https://lifescience.roche.com/en_gb/products/faststart-essential-dna-probes-master.html\"}}}}","ownership_history":[{"name":"Oke Avwenagha ","affiliation":null,"affiliation_url":null,"username":"oke-avwenagha-","link":"","image":{"source":"/img/avatars/004.png","placeholder":"/img/avatars/004.png","webp_source":""},"change_time":1634909742},{"name":"h.morris ","affiliation":null,"affiliation_url":null,"username":"m4wle102z115tle1","link":null,"image":{"source":"/img/avatars/014.png","placeholder":"/img/avatars/014.png","webp_source":""},"change_time":1635246866}],"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"public":true,"public_fork_note":"","published_on":1659644640,"references":[],"related_equipments":[],"reserved_doi":"","retraction_reason":null,"shared_access_id":16,"show_comparison":false,"sign_info":null,"state_version_id":587,"stats":{"is_voted":false,"number_of_views":61,"number_of_steps":12,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":2,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":""},"steps":[{"id":1273886,"guid":"FFF19700333C11EC83F2ADD01087B07A","previous_id":0,"previous_guid":null,"section":"\u003cp\u003e\u003cstrong\u003ePrimer Sequences\u003c/strong\u003e\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2q82j\",\"text\":\"Use the following primer sequences:\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"bq72n\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"11jrh\",\"text\":\"  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"qmi0\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"image\",\"mutability\":\"\",\"data\":{\"guid\":\"238461B0333E11EC83F2ADD01087B07A\",\"height\":164,\"id\":278520,\"is_video\":false,\"legend\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[{\"key\":0,\"length\":83,\"offset\":219}],\"inlineStyleRanges\":[{\"length\":36,\"offset\":0,\"style\":\"bold\"}],\"key\":\"6fvd\",\"text\":\"Table 1: Forward and reverse primers used by Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat. 2000;15(2):181-8. doi: 10.1002/(SICI)1098-1004(200002)15:2\\u003c181::AID-HUMU7\\u003e3.0.CO;2-S. PMID: 10649495.\",\"type\":\"unstyled\"}],\"entityMap\":{\"0\":{\"data\":{\"guid\":\"6B52CC20333E11EC83F2ADD01087B07A\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-1004(200002)15:2%3C181::AID-HUMU7%3E3.0.CO;2-S\"},\"mutability\":\"MUTABLE\",\"type\":\"link\"}}},\"mime\":\"image/png\",\"nestedSelector\":null,\"original_name\":\"Stone et al primer.png\",\"placeholder\":\"https://s3.amazonaws.com/protocols-files/files/ir94bjhbp.jpg\",\"shadow\":false,\"source\":\"https://s3.amazonaws.com/protocols-files/files/ir92bjhbp.jpg\",\"webp_placeholder\":\"https://s3.amazonaws.com/protocols-files/files/ir93bjhbp.webp\",\"webp_source\":\"https://s3.amazonaws.com/protocols-files/files/ir9zbjhbp.webp\",\"width\":550}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"12","duration":0,"original_id":0,"number":"1","cases":[],"critical":[{"id":12,"title":"Critical step","icon":"CriticalIcon"}]},{"id":1273887,"guid":"776DB470333E11EC83F2ADD01087B07A","previous_id":1273886,"previous_guid":"FFF19700333C11EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003eAmplification of the\u003cem\u003e GBA \u003c/em\u003egene\u003c/strong\u003e\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"17j9i\",\"text\":\"Three different PCR reactions are performed. Refer to Table 2 for a detailed description of the PCR conditions used for each fragment.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ailob\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"4","duration":0,"original_id":0,"number":"2","cases":[],"critical":[{"id":4,"title":"PCR","icon":"PCRIcon"}]},{"id":1273888,"guid":"B50B0530333E11EC83F2ADD01087B07A","previous_id":1273887,"previous_guid":"776DB470333E11EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003eAmplification of the\u003cem\u003e GBA \u003c/em\u003egene\u003c/strong\u003e\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"90vva\",\"text\":\"In order to avoid amplification of the pseudogene, primer sequences are designed to bind to DNA regions exclusively found within the GBA gene. As an internal control, calculate the size of the PCR products resulting from amplification of the pseudogene for these three fragments. Confirm they are an alternative size to those amplified from GBA. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":133,\"length\":3},{\"style\":\"italic\",\"offset\":341,\"length\":3}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"2.1","cases":[],"critical":null},{"id":1273889,"guid":"BF68AD20333E11EC83F2ADD01087B07A","previous_id":1273888,"previous_guid":"B50B0530333E11EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003eAmplification of the\u003cem\u003e GBA \u003c/em\u003egene\u003c/strong\u003e\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"a6ndj\",\"text\":\"Amplify three distinct fragments spanning all exonic and most intronic sequences of GBA. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":84,\"length\":3}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"2.2","cases":[],"critical":null},{"id":1273890,"guid":"CABD3830333E11EC83F2ADD01087B07A","previous_id":1273889,"previous_guid":"BF68AD20333E11EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003eAmplification of the\u003cem\u003e GBA \u003c/em\u003egene\u003c/strong\u003e\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":true,"step":"{\"blocks\":[{\"key\":\"1e33r\",\"text\":\"PCR conditions  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c49s9\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4a850\",\"text\":\"  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"pmc2\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"image\",\"mutability\":\"\",\"data\":{\"guid\":\"F9939370333E11EC83F2ADD01087B07A\",\"height\":440,\"id\":278524,\"is_video\":false,\"legend\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[{\"length\":59,\"offset\":0,\"style\":\"bold\"},{\"length\":3,\"offset\":49,\"style\":\"italic\"},{\"length\":3,\"offset\":165,\"style\":\"italic\"},{\"length\":3,\"offset\":222,\"style\":\"italic\"},{\"length\":5,\"offset\":238,\"style\":\"italic\"}],\"key\":\"7bvlv\",\"text\":\"Table 2: PCR conditions for amplification of the GBA gene. Run all PCR products on a 1% agarose gel with ethidium bromide to confirm successful amplification of the GBA gene and to rule out accidental amplification of the GBA pseudogene (GBAP). \",\"type\":\"unstyled\"}],\"entityMap\":{}},\"mime\":\"image/png\",\"nestedSelector\":null,\"original_name\":\"PCR conditions for amplification of the GBA gene.png\",\"placeholder\":\"https://s3.amazonaws.com/protocols-files/files/ir98bjhbp.jpg\",\"shadow\":false,\"source\":\"https://s3.amazonaws.com/protocols-files/files/ir96bjhbp.jpg\",\"webp_placeholder\":\"https://s3.amazonaws.com/protocols-files/files/ir97bjhbp.webp\",\"webp_source\":\"https://s3.amazonaws.com/protocols-files/files/ir95bjhbp.webp\",\"width\":550}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"2.3","cases":[],"critical":null},{"id":1273892,"guid":"94BB2920334011EC83F2ADD01087B07A","previous_id":1273890,"previous_guid":"CABD3830333E11EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"4dasn\",\"text\":\"Prepare the following reagents for the PCR in a total reaction volume of   : \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":73,\"length\":1}],\"data\":{}},{\"key\":\"32mtk\",\"text\":\"  fast start PCR master mix (Roche)\",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":1,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"92p7k\",\"text\":\" of 10 µM Forward primer\",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":2,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"1sk3q\",\"text\":\"  Deionised water \",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":3,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"6ncps\",\"text\":\"  Genomic DNA template (50 ng/µl)\",\"type\":\"ordered-list-item\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":4,\"offset\":0,\"length\":1}],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"amount\",\"mutability\":\"\",\"data\":{\"amount\":\"15\",\"error\":false,\"guid\":\"23BDE0E0334111EC83F2ADD01087B07A\",\"id\":0,\"label\":\"\",\"scientificNotation\":false,\"unit\":1}},\"1\":{\"type\":\"amount\",\"mutability\":\"\",\"data\":{\"amount\":\"7.5\",\"error\":false,\"guid\":\"291D2730334111EC83F2ADD01087B07A\",\"id\":0,\"label\":\"\",\"scientificNotation\":false,\"unit\":1}},\"2\":{\"type\":\"amount\",\"mutability\":\"\",\"data\":{\"amount\":\"1\",\"error\":false,\"guid\":\"2BD123A0334111EC83F2ADD01087B07A\",\"id\":0,\"label\":\"\",\"scientificNotation\":false,\"unit\":1}},\"3\":{\"type\":\"amount\",\"mutability\":\"\",\"data\":{\"amount\":\"4.5\",\"error\":false,\"guid\":\"2E7A98C0334111EC83F2ADD01087B07A\",\"id\":0,\"label\":\"\",\"scientificNotation\":false,\"unit\":1}},\"4\":{\"type\":\"amount\",\"mutability\":\"\",\"data\":{\"amount\":\"1\",\"error\":false,\"guid\":\"31695440334111EC83F2ADD01087B07A\",\"id\":0,\"label\":\"\",\"scientificNotation\":false,\"unit\":1}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"6","duration":0,"original_id":0,"number":"3","cases":[],"critical":[{"id":6,"title":"Mix","icon":"MixIcon"}]},{"id":1273893,"guid":"A8904240334111EC83F2ADD01087B07A","previous_id":1273892,"previous_guid":"94BB2920334011EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7eh3e\",\"text\":\"Run all PCR products on a 1% agarose gel with ethidium bromide and size check to rule out amplification of the GBA pseudogene (GBAP). \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":111,\"length\":3},{\"style\":\"italic\",\"offset\":126,\"length\":6}],\"entityRanges\":[],\"data\":{}},{\"key\":\"3an4m\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"80e9j\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"safety\",\"mutability\":\"\",\"data\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"eupqu\",\"text\":\"Ethidium bromide is a hazardous chemical. It is a risk to the environment, toxic by inhalation and highly toxic as a mutagen. Refer to the product safety data sheet, institutional health \\u0026 safety policies, procedures and risk assessments.\",\"type\":\"unstyled\"}],\"entityMap\":{}}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"4,14","duration":0,"original_id":0,"number":"4","cases":[],"critical":[{"id":4,"title":"PCR","icon":"PCRIcon"},{"id":14,"title":"Toxic","icon":"ToxicIcon"}]},{"id":1273894,"guid":"CB6C0E70334111EC83F2ADD01087B07A","previous_id":1273895,"previous_guid":"A3376F20334211EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"6u4qi\",\"text\":\"Perform cycle sequencing for each exon and the flanking intronic sequences using the Dye Terminator Sequencing Kit (Applied Biosystems) and run on an ABI 3700xl genetic analyzer (Applied Biosystems). \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ala\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6n8rl\",\"text\":\" \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"6","cases":[],"critical":null},{"id":1273895,"guid":"A3376F20334211EC83F2ADD01087B07A","previous_id":1273893,"previous_guid":"A8904240334111EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"a7561\",\"text\":\"If the initial primers failed or showed an incomplete read then and alternative set of primers can be used: \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9rli0\",\"text\":\"Table 3. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"benit\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"eo96a\",\"text\":\"  \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"image\",\"mutability\":\"\",\"data\":{\"guid\":\"7FF32050334611EC83F2ADD01087B07A\",\"height\":269,\"id\":278528,\"is_video\":false,\"legend\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[{\"key\":0,\"length\":19,\"offset\":371}],\"inlineStyleRanges\":[{\"length\":51,\"offset\":0,\"style\":\"bold\"},{\"length\":4,\"offset\":28,\"style\":\"italic\"}],\"key\":\"f5r4c\",\"text\":\"Table 3: Alternative set of GBA sequencing primers reported by  Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 2009 Jul;132(Pt 7):1783-94. doi: 10.1093/brain/awp044. Epub 2009 Mar 13. PMID: 19286695; PMCID: PMC2702833.\",\"type\":\"unstyled\"}],\"entityMap\":{\"0\":{\"data\":{\"guid\":\"1339485C334711ECAF310A58A9FEAC02\",\"url\":\"https://academic.oup.com/brain/article/132/7/1783/324361\"},\"type\":\"link\"}}},\"mime\":\"image/png\",\"nestedSelector\":null,\"original_name\":\"Alternative set of GBA sequencing primers.png\",\"placeholder\":\"https://s3.amazonaws.com/protocols-files/files/isacbjhbp.jpg\",\"shadow\":false,\"source\":\"https://s3.amazonaws.com/protocols-files/files/isaabjhbp.jpg\",\"webp_placeholder\":\"https://s3.amazonaws.com/protocols-files/files/isabbjhbp.webp\",\"webp_source\":\"https://s3.amazonaws.com/protocols-files/files/ir99bjhbp.webp\",\"width\":550}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"5","cases":[],"critical":null},{"id":1273896,"guid":"E4B09A80334211EC83F2ADD01087B07A","previous_id":1273894,"previous_guid":"CB6C0E70334111EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"bph1\",\"text\":\"Sequence all amplicons both in the forward and the reverse direction. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"7","cases":[],"critical":null},{"id":1273897,"guid":"24DC8560334311EC83F2ADD01087B07A","previous_id":1273896,"previous_guid":"E4B09A80334211EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"c4rlo\",\"text\":\"Analyse sequence chromatograms using Sequencher software (Genecodes). \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":58,\"length\":9}],\"data\":{}},{\"key\":\"emc9d\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9fhdu\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":1,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"3rv7k\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"link\",\"mutability\":\"\",\"data\":{\"guid\":\"AF8F3A20364711ECBDBA0F99142C8FC6\",\"url\":\"http://www.genecodes.com/\"}},\"1\":{\"type\":\"notes\",\"mutability\":\"\",\"data\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"3ac8k\",\"text\":\"When this sequencing was carried out NM_001005749 was used.  \",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"7k5br\",\"text\":\"\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"ct59k\",\"text\":\"This RefSeq entry was permanently suppressed because currently there is insufficient support for the transcript and the protein.  \",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"34i77\",\"text\":\"\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"8poan\",\"text\":\"We would now recommend used of variant nomenclature based on the Human Genome Variation Society guidelines (den Dunnen et al., 2016) using GenBank reference sequence NM_000157.4 - describing a 536 amino acid form for glucocerbrosidase.  \",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"8svmp\",\"text\":\"\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"2j4g0\",\"text\":\"NB The traditional numbering for GBA missense mutations omits the first 39 amino acids of the current accepted transcript. \",\"type\":\"unstyled\"}],\"entityMap\":{}}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"7","duration":0,"original_id":0,"number":"8","cases":[],"critical":[{"id":7,"title":"Analyze","icon":"AnalyzeIcon"}]},{"id":1273898,"guid":"2E9B5540334311EC83F2ADD01087B07A","previous_id":1273897,"previous_guid":"24DC8560334311EC83F2ADD01087B07A","section":"\u003cp\u003e\u003cstrong\u003ePCR\u003c/strong\u003e\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"80b9f\",\"text\":\"Analyse all exons and the flanking intronic regions when clean, complete sequence reads are obtained. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9o8mk\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2c3r8\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"8lauh\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9qqio\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"47le2\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"aecpl\",\"text\":\" \",\"type\":\"atomic\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[{\"key\":0,\"offset\":0,\"length\":1}],\"data\":{}},{\"key\":\"45ele\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{\"0\":{\"type\":\"notes\",\"mutability\":\"\",\"data\":{\"blocks\":[{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[{\"length\":14,\"offset\":0,\"style\":\"bold\"}],\"key\":\"4il5h\",\"text\":\"Key references\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[{\"key\":0,\"length\":26,\"offset\":302}],\"inlineStyleRanges\":[],\"key\":\"5phmn\",\"text\":\"Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 2009 Jul;132(Pt 7):1783-94. doi: 10.1093/brain/awp044. Epub 2009 Mar 13. PMID: 19286695; PMCID: PMC2702833.\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"18s5k\",\"text\":\"\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[{\"key\":1,\"length\":66,\"offset\":174}],\"inlineStyleRanges\":[],\"key\":\"ffjf9\",\"text\":\"Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat. 2000;15(2):181-8. doi: 10.1002/(SICI)1098-1004(200002)15:2\\u003c181::AID-HUMU7\\u003e3.0.CO;2-S. PMID: 10649495.\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"cu22m\",\"text\":\"\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[{\"length\":14,\"offset\":250,\"style\":\"italic\"},{\"length\":2,\"offset\":265,\"style\":\"italic\"}],\"key\":\"a566h\",\"text\":\"den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K., Greenblatt, M. S., McGowan-Jordan, J., Roux, A.-F., Smith, T., Antonarakis, S. E., \\u0026 Taschner, P. E. M. (2016). HGVS Recommendations for the Description of Sequence Variants: 2016 Update.Human Mutation,37(6), 564–569.\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[{\"key\":2,\"length\":36,\"offset\":0}],\"inlineStyleRanges\":[],\"key\":\"ekr6d\",\"text\":\"http://dx.doi.org/10.1002/humu.22981  PMID: 26931183\",\"type\":\"unstyled\"},{\"data\":{},\"depth\":0,\"entityRanges\":[],\"inlineStyleRanges\":[],\"key\":\"5lhpt\",\"text\":\"\",\"type\":\"unstyled\"}],\"entityMap\":{\"0\":{\"data\":{\"guid\":\"380C05E0364811ECBDBA0F99142C8FC6\",\"url\":\"https://doi.org/10.1093/brain/awp044\"},\"mutability\":\"\",\"type\":\"link\"},\"1\":{\"data\":{\"guid\":\"60A2CCF0364811ECBDBA0F99142C8FC6\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-1004(200002)15:2%3C181::AID-HUMU7%3E3.0.CO;2-S\"},\"mutability\":\"\",\"type\":\"link\"},\"2\":{\"data\":{\"guid\":\"0F6247B536ED11EC8E100A58A9FEAC02\",\"url\":\"http://dx.doi.org/10.1002/humu.22981\"},\"mutability\":\"\",\"type\":\"link\"}}}}}}","data":null,"protocol_id":54431,"case_id":0,"critical_ids":"7","duration":0,"original_id":0,"number":"9","cases":[],"critical":[{"id":7,"title":"Analyze","icon":"AnalyzeIcon"}]}],"template_id":1,"title":"Glucosylceramidase Beta (GBA) Genotyping","title_html":"\u003cp\u003eGlucosylceramidase Beta (\u003cem\u003eGBA\u003c/em\u003e) Genotyping\u003c/p\u003e","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0},{"id":2,"type_id":3,"name":"mL","can_manage":0},{"id":3,"type_id":3,"name":"L","can_manage":0},{"id":4,"type_id":3,"name":"µg","can_manage":0},{"id":5,"type_id":3,"name":"mg","can_manage":0},{"id":6,"type_id":3,"name":"g","can_manage":0},{"id":7,"type_id":3,"name":"kg","can_manage":0},{"id":8,"type_id":3,"name":"ng","can_manage":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0},{"id":10,"type_id":24,"name":"°C","can_manage":0},{"id":11,"type_id":24,"name":"°К","can_manage":0},{"id":12,"type_id":24,"name":"°F","can_manage":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0},{"id":24,"type_id":3,"name":"μV","can_manage":0},{"id":25,"type_id":3,"name":"ms","can_manage":0},{"id":26,"type_id":3,"name":"pg","can_manage":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0},{"id":34,"type_id":30,"name":"x g","can_manage":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0},{"id":200,"type_id":32,"name":"cm","can_manage":0},{"id":201,"type_id":32,"name":"mm","can_manage":0},{"id":202,"type_id":32,"name":"µm","can_manage":0},{"id":203,"type_id":32,"name":"nm","can_manage":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0}],"uri":"glucosylceramidase-beta-gba-genotyping-bzd7p29n","url":"https://www.protocols.io/view/glucosylceramidase-beta-gba-genotyping-bzd7p29n","version_class":54431,"version_data":{"id":0,"code":"bzd7p29n","version_class":54431,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"version_id":0,"version_uri":"glucosylceramidase-beta-gba-genotyping-q26g78o3qlwz/v1","versions":[{"id":54431,"title":"Glucosylceramidase Beta (GBA) Genotyping","title_html":"\u003cp\u003eGlucosylceramidase Beta (\u003cem\u003eGBA\u003c/em\u003e) Genotyping\u003c/p\u003e","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.bzd7p29n","uri":"glucosylceramidase-beta-gba-genotyping-bzd7p29n","published_on":1635416476,"modified_on":1659644640,"version_class":54431,"version_id":0,"version_code":"bzd7p29n","version_uri":"glucosylceramidase-beta-gba-genotyping-q26g78o3qlwz/v1","created_on":1634909742,"categories":null,"creator":{"name":"h.morris ","affiliation":null,"affiliation_url":null,"username":"m4wle102z115tle1","link":null,"image":{"source":"/img/avatars/014.png","placeholder":"/img/avatars/014.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":"{\"blocks\":[{\"key\":\"93h0n\",\"text\":\"Ethidium bromide is hazardous chemical. It is a risk to the environment, toxic by inhalation and highly toxic as a mutagen. Refer to the product safety data sheet and institutional health \\u0026 safety policies and procedures and risk assessments.\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}"}